The coffee break biotech roundup, by SomX.
It's interesting how you framed the diagnostic dilemma here. How do you see the biotech world closing that significant gap between early warning and actual therapeutic action?
It's interesting how you framed the diagnostic dilemma here. How do you see the biotech world closing that significant gap between early warning and actual therapeutic action?